Clinical Trials Browser

Phase 1 × INDUSTRY × CTL019 chimeric antigen receptor × Clear all

NCT02810223 2016-10-14

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma